Skip to main content
Erschienen in: Rheumatology International 2/2009

01.12.2009 | Short Communication

TNF-α gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease

verfasst von: Mortaza Bonyadi, Zohreh Jahanafrooz, Mohsen Esmaeili, Susan Kolahi, Alireza Khabazi, Ali Asghar Ebrahimi, Mehrzad Hajialilo, Saeed Dastgiri

Erschienen in: Rheumatology International | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Genetic factors that predispose individuals to Behcet’s disease (BD) are considered to play an important role in the development of the disease. The serum level of tumor necrosis factor (TNF) is elevated in patients with BD, and a dramatic response to anti-TNF-α antibody treatment further supports the role of TNF in BD. We investigated the distribution of TNF-α promoter −1031T/C and −308G/A polymorphisms in 53 BD patients of Iranian Azeri Turks and 79 matched healthy controls, via the PCR–RFLP technique. The frequency of the TNF-α −1031C allele was significantly higher in Behcet’s patients than in healthy controls (p < 0.0001, OR = 3.08; 95% CI = 1.73–5.47), whereas the frequency of the TNF-α −308A allele was similar in the two compared groups. The frequency of CG haplotype was significantly higher (p < 0.0001, OR = 3.42; 95% CI = 1.89–6.18), and that of the TA haplotype was significantly lower in BD patients than in healthy controls. These results suggest that TNF-α is a susceptibility gene for BD in patients from Iranian Azeri Turk ethnic group.
Literatur
1.
Zurück zum Zitat Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F et al (2007) IL-10 genotype analysis in patients with Behcet’s disease. Hum Immunol 68:122–127CrossRefPubMed Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F et al (2007) IL-10 genotype analysis in patients with Behcet’s disease. Hum Immunol 68:122–127CrossRefPubMed
2.
Zurück zum Zitat Harmouche H, Maamar M, Sahnoune I, Tazi-Mezalek Z, Aouni M, Maaouni A (2007) Fever revealing Behcet’s disease: two new cases. Eur J Intern Med 18:146–147CrossRefPubMed Harmouche H, Maamar M, Sahnoune I, Tazi-Mezalek Z, Aouni M, Maaouni A (2007) Fever revealing Behcet’s disease: two new cases. Eur J Intern Med 18:146–147CrossRefPubMed
3.
Zurück zum Zitat Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behcet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295CrossRefPubMed Schwartz T, Langevitz P, Zemer D, Gazit E, Pras M, Livneh A (2000) Behcet’s disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 29:286–295CrossRefPubMed
4.
Zurück zum Zitat Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829CrossRefPubMed Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829CrossRefPubMed
5.
Zurück zum Zitat Gul A, Inanc M, Ocal L, Aral O, Konice M (2000) Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis 59:622–625CrossRefPubMed Gul A, Inanc M, Ocal L, Aral O, Konice M (2000) Familial aggregation of Behcet’s disease in Turkey. Ann Rheum Dis 59:622–625CrossRefPubMed
6.
Zurück zum Zitat Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213–220CrossRefPubMed Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213–220CrossRefPubMed
7.
Zurück zum Zitat Durrani K, Papaliodis GN (2008) The genetics of Adamantiades–Behcet’s disease. Semin Ophthalmol 23:73–79CrossRefPubMed Durrani K, Papaliodis GN (2008) The genetics of Adamantiades–Behcet’s disease. Semin Ophthalmol 23:73–79CrossRefPubMed
8.
Zurück zum Zitat Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumor necrosis factor-alpha levels are increased in Behcet’s disease. Clin Exp Dermatol 30:61–63CrossRefPubMed Oztas MO, Onder M, Gurer MA, Bukan N, Sancak B (2005) Serum interleukin 18 and tumor necrosis factor-alpha levels are increased in Behcet’s disease. Clin Exp Dermatol 30:61–63CrossRefPubMed
9.
Zurück zum Zitat Ates A, Kinikli G, Duzgun N, Duman M (2006) Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behcet’s disease. Rheumatol Int 26:348–353CrossRefPubMed Ates A, Kinikli G, Duzgun N, Duman M (2006) Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behcet’s disease. Rheumatol Int 26:348–353CrossRefPubMed
10.
Zurück zum Zitat Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H et al (1998) Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605–612CrossRefPubMed Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H et al (1998) Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605–612CrossRefPubMed
11.
Zurück zum Zitat Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Immunology 94:3195–3199 Wilson AG, Symons JA, Mcdowell TL, Mcdevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Immunology 94:3195–3199
12.
Zurück zum Zitat van Heel DA, Udalova IA, De Silva AP, Mc Govern DP, Kinouchi Y, Hull J et al (2002) Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet 11:1281–1289CrossRefPubMed van Heel DA, Udalova IA, De Silva AP, Mc Govern DP, Kinouchi Y, Hull J et al (2002) Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet 11:1281–1289CrossRefPubMed
13.
Zurück zum Zitat Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA et al (2001) A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166:7023–7032PubMed Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA et al (2001) A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166:7023–7032PubMed
14.
Zurück zum Zitat Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363–366CrossRefPubMed Zuniga J, Vargas-Alarcon G, Hernandez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J (2001) Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363–366CrossRefPubMed
15.
Zurück zum Zitat International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080 International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
16.
Zurück zum Zitat Miller SA, Dynes DD, Polesky F (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRefPubMed Miller SA, Dynes DD, Polesky F (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215CrossRefPubMed
17.
Zurück zum Zitat Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K et al (2003) Mapping the HLA association in Behcet’s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813CrossRefPubMed Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K et al (2003) Mapping the HLA association in Behcet’s disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813CrossRefPubMed
18.
Zurück zum Zitat Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki H, Tsuji K, Inoko H (1995) Microsatellite polymorphism located between the TNF and HLA-B genes in Behcet’s disease. Hum Immunol 43:129–135CrossRefPubMed Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki H, Tsuji K, Inoko H (1995) Microsatellite polymorphism located between the TNF and HLA-B genes in Behcet’s disease. Hum Immunol 43:129–135CrossRefPubMed
19.
Zurück zum Zitat Park K, Kim N, Nam J, Bang D, Lee ES (2006) Association of TNFA promoter region haplotype in Behcet’s disease. J Korean Med Sci 21:596–601CrossRefPubMed Park K, Kim N, Nam J, Bang D, Lee ES (2006) Association of TNFA promoter region haplotype in Behcet’s disease. J Korean Med Sci 21:596–601CrossRefPubMed
20.
Zurück zum Zitat Lee EB, Kim JY, Lee YJ, Park MH, Song YW (2003) TNF and TNF receptor polymorphisms in Korean Behcet’s disease patients. Hum Immunol 64:614–620PubMed Lee EB, Kim JY, Lee YJ, Park MH, Song YW (2003) TNF and TNF receptor polymorphisms in Korean Behcet’s disease patients. Hum Immunol 64:614–620PubMed
21.
Zurück zum Zitat Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E et al (2006) TNF-a gene 1031 T/C polymorphism in Turkish patients with Behcet’s disease. Br J Dermatol 155:350–356CrossRefPubMed Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E et al (2006) TNF-a gene 1031 T/C polymorphism in Turkish patients with Behcet’s disease. Br J Dermatol 155:350–356CrossRefPubMed
22.
Zurück zum Zitat Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K (2007) Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet’s disease. Hum Immunol 68:201–205CrossRefPubMed Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K (2007) Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet’s disease. Hum Immunol 68:201–205CrossRefPubMed
23.
Zurück zum Zitat Ben Dhifallah I, Houman H, Khanfir M, Hamzaoui K (2008) Endothelial nitric oxide synthase gene polymorphism is associated with Behcet’s disease in Tunisian population. Hum Immunol 69:661–665CrossRefPubMed Ben Dhifallah I, Houman H, Khanfir M, Hamzaoui K (2008) Endothelial nitric oxide synthase gene polymorphism is associated with Behcet’s disease in Tunisian population. Hum Immunol 69:661–665CrossRefPubMed
24.
Zurück zum Zitat Lee YJ, Kang SW, Song JK, Baek HJ, Choi HJ, Bae YD et al (2007) Associations between interferon regulatory factor-1 polymorphisms and Behcet’s disease. Hum Immunol 68:770–778CrossRefPubMed Lee YJ, Kang SW, Song JK, Baek HJ, Choi HJ, Bae YD et al (2007) Associations between interferon regulatory factor-1 polymorphisms and Behcet’s disease. Hum Immunol 68:770–778CrossRefPubMed
25.
Zurück zum Zitat Sahin N, Bicakcigil M, Atagunduz P, Direskeneli H, Saruhan-Direskeneli G (2007) PTPN22 gene polymorphism in Behcet’s disease. Tissue Antigens 70:432–434CrossRefPubMed Sahin N, Bicakcigil M, Atagunduz P, Direskeneli H, Saruhan-Direskeneli G (2007) PTPN22 gene polymorphism in Behcet’s disease. Tissue Antigens 70:432–434CrossRefPubMed
26.
Zurück zum Zitat Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F et al (2007) The association of the PTPN22 620 W polymorphism with Behcet’s disease. Ann Rheum Dis 66:1531–1533CrossRefPubMed Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F et al (2007) The association of the PTPN22 620 W polymorphism with Behcet’s disease. Ann Rheum Dis 66:1531–1533CrossRefPubMed
27.
Zurück zum Zitat Touitou I, Magne X, Molinari N, Navarro A, Le Quellec A, Picco P et al (2000) MEFV mutations in Behcet’s disease. Hum Mutat 16:271–272CrossRefPubMed Touitou I, Magne X, Molinari N, Navarro A, Le Quellec A, Picco P et al (2000) MEFV mutations in Behcet’s disease. Hum Mutat 16:271–272CrossRefPubMed
28.
Zurück zum Zitat Kone-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I (2007) Autoinflammatory gene mutations in Behcet’s disease. Ann Rheum Dis 66:832–834CrossRefPubMed Kone-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I (2007) Autoinflammatory gene mutations in Behcet’s disease. Ann Rheum Dis 66:832–834CrossRefPubMed
29.
Zurück zum Zitat Gul A (2005) Behcet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83CrossRefPubMed Gul A (2005) Behcet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83CrossRefPubMed
30.
Zurück zum Zitat Schlesselman J (1982) Case–control studies: design, conduct, analysis, equation 6.6 and 6.7: sample size determination with an unequal case–control ratio. Oxford, New York Schlesselman J (1982) Case–control studies: design, conduct, analysis, equation 6.6 and 6.7: sample size determination with an unequal case–control ratio. Oxford, New York
Metadaten
Titel
TNF-α gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease
verfasst von
Mortaza Bonyadi
Zohreh Jahanafrooz
Mohsen Esmaeili
Susan Kolahi
Alireza Khabazi
Ali Asghar Ebrahimi
Mehrzad Hajialilo
Saeed Dastgiri
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 2/2009
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1134-x

Weitere Artikel der Ausgabe 2/2009

Rheumatology International 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.